Erratum: Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor (Mol Cell Biochem, (2011), 346(1-2), (125-126), 10.1007/s11010-010-0599-y);Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor

Molecular and Cellular Biochemistry

Volumn 346, Issue 1-2, 2011, Pages 125-136

  Kim, Jong Myung ^a   Song, Ji Sun ^a   Cho, Hyun Hwa ^a   Shin, Keun Koo ^a   Bae, Yong Chan ^a   Lee, Byung Ju ^a   Jung, Jin Sup ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Lzts2; NF B; Proliferation; Transcriptional regulation; Tumor growth; catenin

Indexed keywords

BETA CATENIN; CISPLATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; LEUCINE ZIPPER TUMOR SUPPRESSOR 2 PROTEIN; T CELL FACTOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CARCINOGENICITY; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; COLON CANCER; CONTROLLED STUDY; DRUG SENSITIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; LENTIVIRINAE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROSTATE CANCER; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

EID: 78751624930     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1177-7     Document Type: Erratum

References (31)

1. CY Logan R Nusse 2004 The Wnt signaling pathway in development and disease Annu Rev Cell Dev Biol 20 781 810 1:CAS:528:DC%2BD2cXhtVejsr7I 10.1146/annurev.cellbio.20.010403.113126 15473860 (Pubitemid 39488658)
2. BT MacDonald K Tamai X He 2009 Wnt/beta-catenin signaling: components, mechanisms, and diseases Dev Cell 17 9 26 1:CAS:528:DC%2BD1MXpsV2msb8%3D 10.1016/j.devcel.2009.06.016 19619488
3. YS Bian MC Osterheld FT Bosman C Fontolliet J Benhattar 2000 Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus Am J Clin Pathol 114 583 590 1:CAS:528:DC%2BD3cXnt1KntLk%3D 10.1309/3QLC-5MF1-JYXU-A5XX 11026105 (Pubitemid 33044398)
4. CG Eberhart T Tihan PC Burger 2000 Nuclear localization and mutation of beta-catenin in medulloblastomas J Neuropathol Exp Neurol 59 333 337 1:CAS:528:DC%2BD3cXisleis7c%3D 10759189
5. Q Li IM Verma 2002 NF-κB regulation in the immune system Nat Rev Immunol 2 725 734 1:CAS:528:DC%2BD38XnsVGqsbg%3D 10.1038/nri910 12360211 (Pubitemid 37328713)
6. A Lin M Karin 2003 NF-κB in cancer: a marked target Semin Cancer Biol 13 107 114 1:CAS:528:DC%2BD3sXitlWnsL8%3D 10.1016/S1044-579X(02)00128-1 12654254 (Pubitemid 36315929)
7. MW Mayo AS Baldwin 2000 The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance Biochim Biophys Acta 1470 M55 M62 1:CAS:528:DC%2BD3cXhvFOhsbw%3D 10722927
8. S Prasad J Ravindran BB Aggarwal 2010 NF-kappaB and cancer: how intimate is this relationship Mol Cell Biochem 336 25 37 1:CAS:528:DC%2BC3cXitlKisbg%3D 10.1007/s11010-009-0267-2 19823771
9. AA Chang C Van Waes 2005 Nuclear factor-kappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma Adv Otorhinolaryngol 62 92 102 1:CAS:528:DC%2BD2MXksFyqug%3D%3D 15608421
10. C Pepper S Hewamana P Brennan C Fegan 2009 NF-kappaB as a prognostic marker and therapeutic target in chronic lymphocytic leukemia Future Oncol 5 1027 1237 1:CAS:528:DC%2BD1MXht1Skt7zF 10.2217/fon.09.72 19792971
11. J Deng, et al. 2002 Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer Cancer Cell 2 323 334 1:CAS:528: DC%2BD38Xot1Gkt7Y%3D 10.1016/S1535-6108(02)00154-X 12398896 (Pubitemid 41043966)
12. P Polakis 2000 Wnt signaling and cancer Genes Dev 14 1837 1851 1:CAS:528:DC%2BD3cXls1yqsbc%3D 10921899
13. KP Hoeflich J Luo EA Rubie MS Tsao O Jin JR Woodgett 2000 Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation Nature 406 86 90 1:CAS:528:DC%2BD3cXlt12rtbY%3D 10.1038/35017574 10894547 (Pubitemid 30460216)
14. X Wang N Adhikari Q Li Z Guan JL Hall 2004 The role of [beta]-transducin repeat containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells Arterioscler Thromb Vasc 24 85 90 10.1161/01.ATV.0000104012.40720.c4 (Pubitemid 38082416)
15. HH Cho HJ Joo JS Song YC Bae JS Jung 2007 Crossregulation of β-catenin/Tcf pathway by NF-κB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells Biochim Biophys Acta 26 8857 8867
16. G Thyssen TH Li L Lehmann M Zhuo M Sharma Z Sun 2006 LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin Mol Cell Biol 26 8857 8867 1:CAS:528:DC%2BD28Xht1yqsLnK 10.1128/MCB.01031-06 17000760 (Pubitemid 44851944)
17. HH Cho JS Song JM Yu SS Yu SJ Choi DH Kim JS Jung 2008 Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells FEBS Lett 582 616 622 1:CAS:528:DC%2BD1cXisVSqsb4%3D 10.1016/j.febslet.2008.01. 029 18242184
18. V Bours M Bentires-Alj AC Hellin P Viatour P Robe S Delhalle V Benoit MP Merville 2000 Nuclear factor-kappa B, cancer, and apoptosis Biochem Pharmacol 60 1085 1089 1:CAS:528:DC%2BD3cXmslOjsb8%3D 10.1016/S0006-2952(00)00391-9 11007945
19. J Zhu F He S Hu J Yu 2008 On the nature of human housekeeping genes Trends Genet 24 481 484 1:CAS:528:DC%2BD1cXhtFOltbbF 10.1016/j.tig.2008.08.004 18786740
20. JA Goodrich G Cutler R Tjian 1996 Contacts in context: promoter specificity and macromolecular interactions in transcription Cell 84 825 830 1:CAS:528:DyaK28XhvFKjsr0%3D 10.1016/S0092-8674(00)81061-2 8601306 (Pubitemid 26111054)
21. R Janknecht T Hunter 1996 Transcription. A growing coactivator network Nature 383 22 23 1:CAS:528:DyaK28XlsVyqtbo%3D 10.1038/383022a0 8779707 (Pubitemid 26296442)
22. H Sun WC Chung SH Ryu Z Ju HT Tran E Kim JM Kurie JS Koo 2008 Cyclic AMP-responsive element binding protein- and nuclear factor-{kappa}B-regulated CXC chemokine gene expression in lung carcinogenesis Cancer Prev Res 1 316 328 1:CAS:528:DC%2BC3cXptFOitrg%3D 10.1158/1940-6207.CAPR-07-0002
23. T Yabe T Sanagi JP Schwartz H Yamada 2005 Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB Glia 50 223 234 10.1002/glia.20171 15739190 (Pubitemid 40769852)
24. GC Parry N Mackman 1997 Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription J Immunol 159 5450 5456 1:CAS:528:DyaK2sXnslOjsLg%3D 9548485
25. M Delgado EJ Munoz-Elias Y Kan I Gozes M Fridkin DE Brenneman RP Gomariz D Ganea 1998 Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun J Biol Chem 273 31427 31436 1:CAS:528: DyaK1cXns1ens7k%3D 10.1074/jbc.273.47.31427 9813054 (Pubitemid 28533162)
26. E López-Knowles SJ Zardawi CM McNeil EK Millar P Crea EA Musgrove RL Sutherland SA O'Toole 2010 Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients Cancer Epidemiol Biomark Prev 19 301 309 10.1158/1055-9965.EPI-09-0741
27. G Sethi B Sung BB Aggarwal 2008 Nuclear factor-kappaB activation: from bench to bedside Exp Biol Med (Maywood) 233 21 31 1:CAS:528: DC%2BD1cXhsVeqsQ%3D%3D 10.3181/0707-MR-196
28. C Nakanishi M Toi 2005 Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs Nat Rev Cancer 5 297 309 1:CAS:528:DC%2BD2MXivVars7Y%3D 10.1038/nrc1588 15803156 (Pubitemid 40488635)
29. CY Wang MW Mayo AS Baldwin Jr 1996 TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 274 784 787 1:CAS:528:DyaK28XmsFOhu7Y%3D 10.1126/science.274.5288.784 8864119 (Pubitemid 26398259)
30. D Ji SL Deeds EJ Weinstein 2007 A screen of shRNAs targeting tumor suppressor genes to identify factors involved in A549 paclitaxel sensitivity Oncol Rep 18 1499 1505 1:CAS:528:DC%2BD2sXhsVKgurjM 17982636
31. G Saldanha V Ghura L Potter A Fletcher 2004 Nuclear β-catenin in basal cell carcinoma correlates with increased proliferation Br J Dermatol 151 157 164 1:CAS:528:DC%2BD2cXns1Sjtr4%3D 10.1111/j.1365-2133.2004.06048.x 15270885 (Pubitemid 39061293)